{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T18:31:02Z","timestamp":1769106662030,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Analytica Chimica Acta"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.aca.2014.04.015","type":"journal-article","created":{"date-parts":[[2014,4,12]],"date-time":"2014-04-12T20:01:05Z","timestamp":1397332865000},"page":"54-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["3,4-Methylenedioxypyrovalerone (MDPV) and metabolites quantification in human and rat plasma by liquid chromatography\u2013high resolution mass spectrometry"],"prefix":"10.1016","volume":"827","author":[{"given":"Sebastien","family":"Anizan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayla","family":"Ellefsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Concheiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenner C.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael H.","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilyn A.","family":"Huestis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.aca.2014.04.015_bib0005","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/S0196-0644(05)80419-6","article-title":"Methcathinone: a Russian designer amphetamine infiltrates the rural midwest","volume":"22","author":"Emerson","year":"1993","journal-title":"Annals of Emergency Medicine"},{"key":"10.1016\/j.aca.2014.04.015_bib0010","article-title":"Bath salts and synthetic cathinones: an emerging designer drug phenomenon","author":"German","year":"2013","journal-title":"Life Sciences"},{"issue":"7\u20138","key":"10.1016\/j.aca.2014.04.015_bib0015","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/dta.313","article-title":"Cathinone derivatives: a review of their chemistry, pharmacology and toxicology","volume":"3","author":"Kelly","year":"2011","journal-title":"Drug Testing and Analysis"},{"issue":"1","key":"10.1016\/j.aca.2014.04.015_bib0020","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s13181-011-0193-z","article-title":"The toxicology of bath salts: a review of synthetic cathinones","volume":"8","author":"Prosser","year":"2012","journal-title":"Journal of Medical Toxicology"},{"key":"10.1016\/j.aca.2014.04.015_bib0025","doi-asserted-by":"crossref","DOI":"10.1111\/1556-4029.12202","article-title":"Methylenedioxypyrovalerone (\u201cbath salts\u201d), related death: case report and review of the literature","author":"Kesha","year":"2013","journal-title":"Journal of Forensic Sciences"},{"issue":"1","key":"10.1016\/j.aca.2014.04.015_bib0030","first-page":"12","article-title":"The characterization of 3,4-methylenedioxypyrovalerone (MDPV)","volume":"7","author":"Yohannan","year":"2010","journal-title":"Microgram Journal"},{"issue":"1\u20133","key":"10.1016\/j.aca.2014.04.015_bib0035","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.forsciint.2013.04.015","article-title":"Designer cathinones\u2014an emerging class of novel recreational drugs","volume":"231","author":"Zawilska","year":"2013","journal-title":"Forensic Science International"},{"issue":"6","key":"10.1016\/j.aca.2014.04.015_bib0040","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3109\/15563650.2011.590812","article-title":"Clinical experience with and analytical confirmation of \u201cbath salts\u201d and \u201clegal highs\u201d (synthetic cathinones) in the United States","volume":"49","author":"Spiller","year":"2011","journal-title":"Clinical Toxicology (Philadelphia)"},{"issue":"1","key":"10.1016\/j.aca.2014.04.015_bib0045","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.annemergmed.2012.01.005","article-title":"Hyperthermia and multiorgan failure after abuse of \u201cbath salts\u201d containing 3,4-methylenedioxypyrovalerone","volume":"60","author":"Borek","year":"2012","journal-title":"Annals of Emergency Medicine"},{"issue":"12","key":"10.1016\/j.aca.2014.04.015_bib0050","first-page":"375","article-title":"Illicit bath salts: not for bathing","volume":"52","author":"Kyle","year":"2011","journal-title":"Journal of the Mississippi State Medical Association"},{"issue":"2","key":"10.1016\/j.aca.2014.04.015_bib0055","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1476-5381.2012.02145.x","article-title":"Pharmacological characterization of designer cathinones in vitro","volume":"168","author":"Simmler","year":"2013","journal-title":"British Journal of Pharmacology"},{"issue":"7","key":"10.1016\/j.aca.2014.04.015_bib0060","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1111\/bph.12061","article-title":"Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter","volume":"168","author":"Cameron","year":"2013","journal-title":"British Journal of Pharmacology"},{"issue":"4","key":"10.1016\/j.aca.2014.04.015_bib0065","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/npp.2012.204","article-title":"Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive \u2018bath salts' products","volume":"38","author":"Baumann","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"18","key":"10.1016\/j.aca.2014.04.015_bib0070","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1002\/rcm.4692","article-title":"Toxicological determination and in vitro metabolism of the designer drug methylenedioxypyrovalerone (MDPV) by gas chromatography\/mass spectrometry and liquid chromatography\/quadrupole time-of-flight mass spectrometry","volume":"24","author":"Strano-Rossi","year":"2010","journal-title":"Rapid Communications in Mass Spectrometry"},{"issue":"12","key":"10.1016\/j.aca.2014.04.015_bib0075","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/jms.1859","article-title":"Studies on the metabolism of the \u03b1-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat and human urine and human liver microsomes using GC\u2013MS and LC\u2013high-resolution MS and its detectability in urine by GC\u2013MS","volume":"45","author":"Meyer","year":"2010","journal-title":"Journal of Mass Spectrometry"},{"issue":"5","key":"10.1016\/j.aca.2014.04.015_bib0080","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1002\/hlca.19640470524","article-title":"Die STEVENS \u2013 umlagerung von allyl-phenacyl-ammoniumsalzen","volume":"47","author":"Heffe","year":"1964","journal-title":"Helvetica Chimica Acta"},{"issue":"4","key":"10.1016\/j.aca.2014.04.015_bib0085","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1021\/jm050797a","article-title":"1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (pyrovalerone) analogues: a promising class of monoamine uptake inhibitors","volume":"49","author":"Meltzer","year":"2006","journal-title":"Journal of Medicinal Chemistry"},{"issue":"29","key":"10.1016\/j.aca.2014.04.015_bib0090","doi-asserted-by":"crossref","first-page":"9437","DOI":"10.1007\/s00216-013-7386-z","article-title":"Simultaneous quantification of 28 synthetic cathinones and metabolites in urine by liquid chromatography\u2013high resolution mass spectrometry","volume":"405","author":"Concheiro","year":"2013","journal-title":"Analytical and Bioanalytical Chemistry"},{"issue":"2","key":"10.1016\/j.aca.2014.04.015_bib0095","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/clinchem\/30.2.290","article-title":"How to improve estimates of imprecision","volume":"30","author":"Krouwer","year":"1984","journal-title":"Clinical Chemistry"},{"issue":"Suppl 1","key":"10.1016\/j.aca.2014.04.015_bib0100","first-page":"S23","article-title":"Evaluating assay precision","volume":"29","author":"Chesher","year":"2008","journal-title":"Clinical Biochemist Reviews"},{"issue":"13","key":"10.1016\/j.aca.2014.04.015_bib0105","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC\u2013MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Analytical Chemistry"},{"issue":"7","key":"10.1016\/j.aca.2014.04.015_bib0110","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/anatox\/35.7.470","article-title":"(\u00b1)-3,4-Methylenedioxymethamphetamine and metabolite disposition in plasma and striatum of wild-type and multidrug resistance protein 1a knock-out mice","volume":"35","author":"Scheidweiler","year":"2011","journal-title":"Journal of Analytical Toxicology"},{"issue":"6\u20137","key":"10.1016\/j.aca.2014.04.015_bib0115","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s00216-009-2607-1","article-title":"Hydrolysis of 3,4-methylenedioxymethamphetamine (MDMA) metabolite conjugates in human, squirrel monkey, and rat plasma","volume":"393","author":"Mueller","year":"2009","journal-title":"Analytical and Bioanalytical Chemistry"},{"issue":"5","key":"10.1016\/j.aca.2014.04.015_bib0120","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/jat\/bks033","article-title":"Rapid and sensitive analysis of 3,4-methylenedioxypyrovalerone in equine plasma using liquid chromatography\u2013tandem mass spectrometry","volume":"36","author":"Wang","year":"2012","journal-title":"Journal of Analytical Toxicology"},{"issue":"1\u20133","key":"10.1016\/j.aca.2014.04.015_bib0125","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.forsciint.2011.03.015","article-title":"New designer drug of abuse: 3,4-methylenedioxypyrovalerone (MDPV). Findings from apprehended drivers in Finland","volume":"210","author":"Kriikku","year":"2011","journal-title":"Forensic Science International"},{"issue":"3","key":"10.1016\/j.aca.2014.04.015_bib0130","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/jat\/bks136","article-title":"Analysis of synthetic cathinones commonly found in bath salts in human performance and postmortem toxicology: method development, drug distribution and interpretation of results","volume":"37","author":"Marinetti","year":"2013","journal-title":"Journal of Analytical Toxicology"},{"key":"10.1016\/j.aca.2014.04.015_bib0135","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1021\/tx010051p","article-title":"3,4-Dihydroxymethamphetamine (HHMA). A major in vivo 3,4-methylenedioxymethamphetamine (MDMA) metabolite in humans","volume":"14","author":"Segura","year":"2001","journal-title":"Chemical Research in Toxicology"},{"issue":"2","key":"10.1016\/j.aca.2014.04.015_bib0140","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jchromb.2007.06.034","volume":"855","author":"Mueller","year":"2007","journal-title":"Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences"},{"issue":"2","key":"10.1016\/j.aca.2014.04.015_bib0145","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/jat\/bks138","article-title":"The stability of four designer drugs: MDPV, mephedrone, BZP and TFMPP in three biological matrices under various storage conditions","volume":"37","author":"Johnson","year":"2013","journal-title":"Journal of Analytical Toxicology"}],"container-title":["Analytica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003267014004243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003267014004243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T18:11:03Z","timestamp":1597687863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003267014004243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":29,"alternative-id":["S0003267014004243"],"URL":"https:\/\/doi.org\/10.1016\/j.aca.2014.04.015","relation":{},"ISSN":["0003-2670"],"issn-type":[{"value":"0003-2670","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"3,4-Methylenedioxypyrovalerone (MDPV) and metabolites quantification in human and rat plasma by liquid chromatography\u2013high resolution mass spectrometry","name":"articletitle","label":"Article Title"},{"value":"Analytica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aca.2014.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}